1Nieminen MS,Bohm M,Cowie MR.Executive summary of the guidelines on the diagnosis and treatment of acute heart failure:the task force on acute heart failure of The European Society of Cardiology[J].Europ Heart J,2005,26:384-416.
1Remme WJ, Swedberg K. European society of cardiology: com prehensive guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure of the european society of cardiology. Eur J Heart Fail ,2002,4( 1 ) :11-22.
2McDonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet, 1998,35). (9095) :9-13.
3Luchner A, Stevens TL, Borgeson DD, et al. Differential atria and ventricular expression of myocardial BNP during evolution of heart failure. Am J Physiol,1998,274(5 Pt 2) :H1684-H1689,
4Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care sctting. J Am Coll Cardiol,2001,37(2) :379-385.
2Vanderheyden, M, Vrints, C, Verstreken, S, et al. β-type natriuretic peptide as a morlcer of heart failure:new insights from biochemistry and clinical implications[J]. Biomark Med, 2010,4 : 315-320.
